Publications (13)47.41 Total impact
-
Article: Tbx5 overexpression favors a first heart field lineage in murine embryonic stem cells and in Xenopus laevis embryos.
[show abstract] [hide abstract]
ABSTRACT: The T-box transcription factor Tbx5 is involved in several developmental processes including cardiogenesis. Early steps of cardiac development are characterised by the formation of two cardiogenic lineages, the first (FHF) and the second heart field (SHF) lineage, which arise from a common cardiac progenitor cell population. To further investigate the function of Tbx5 during cardiogenesis, we generated a murine embryonic stem cell line constitutively overexpressing Tbx5. Differentiation of these cells is characterised by an earlier and increased appearance of contracting cardiomyocytes that beat with a higher frequency than control cells. In semi-quantitative and quantitative RT-PCR analyses, we observed an up-regulation of cardiac marker genes such as Troponin T, endogenous Tbx5, and Nkx2.5 and a down-regulation of others like BMP4 and Hand2. Similar data were gained in Xenopus laevis arguing for a conserved function of Tbx5. Furthermore, markers of the conduction system and atrial cardiomyocytes were increased.Developmental Dynamics 12/2011; 240(12):2634-45. · 2.54 Impact Factor -
Article: Characterization of Danio rerio Nanog and functional comparison to Xenopus Vents.
[show abstract] [hide abstract]
ABSTRACT: Nanog is a homeodomain transcription factor associated with the acquisition of pluripotency. Genome analyses of lower and higher vertebrates revealed that the existence of Nanog is restricted to gnathostomata but absent from agnatha and invertebrates. To elucidate the function of Nanog in nonmammalia, we identified the Danio rerio ortholog of Nanog and characterized its role in gain and loss of function experiments. We found Nanog to be crucial for survival of early zebrafish embryos, because depletion of Nanog led to gastrulation defects with subsequent lethality. Mouse Nanog overexpression could rescue these defects. Vice versa, zebrafish Nanog was found to promote proliferation and to inhibit differentiation of mouse embryonic stem cells in the absence of leukemia inhibitory factor. These findings indicate functional conservation of Nanog from teleost fishes to mammals. However, Nanog was lost in the genome of the anurans Xenopus laevis and Xenopus tropicalis. Phylogenetic analysis revealed that deletion probably occurred in a common anuran ancestor along with chromosomal translocations. The closest homologs of Nanog in Xenopus are the Vent proteins. We, therefore, investigated whether the Xvent genes might substitute for Nanog function in Xenopus. Although we found some similarities in phenotypes after overexpression and in the regulation of several marker genes, Xvent1/2 and Nanog cannot substitute each other. Depletion of Nanog in zebrafish cannot be rescued by ectopic expression of Xvent, and Xvent depletion in Xenopus cannot be overcome by ectopic expression of zebrafish Nanog.Stem cells and development 10/2011; 21(8):1225-38. · 4.15 Impact Factor -
Article: Identification of Sprouty-related protein with EVH-1 domain (SPRED) 2 as a negative regulator of the Hypothalamic-Pituitary-Adrenal (HPA) axis
[show abstract] [hide abstract]
ABSTRACT: SPREDs are inhibitors of mitogen-activated protein kinase (MAPK) signaling. To elucidate SPRED2 in vivo function, we characterized body homeostasis in SPRED2-/- mice. They showed a doubled daily water uptake, induced by elevated serum osmolality, originating from increased blood salt load. Doubled serum aldosterone was accompanied by augmented adrenal aldosterone synthase expression. Surprisingly, serum vasopressin was unaltered and, evidenced by halved angiotensin II levels, the renin angiotensin system was down-regulated. Adrenocorticotropic hormone (ACTH) was significantly elevated in SPRED2-/- mice, together with its secretagogue corticotropin-releasing hormone (CRH) and its downstream target corticosterone. Extracellular signal-regulated kinase (ERK) phosphorylation in brains was augmented and hypothalamic CRH mRNA levels were elevated, both contributing to the increased CRH release. Our data were supported by CRH promoter reporter assays in hypothalamic mHypoE-44 cells, revealing a SPRED-dependent inhibition of ERK/E-twenty six (Ets)-dependent transcription. Furthermore, SPRED suppressed CRH production in these cells. In conclusion, our study suggests that SPRED2-deficiency leads to an increased MAPK signaling, which results in an augmented CRH promoter activity. The subsequent CRH overproduction causes a thereof dependent up-regulation of HPA hormone secretion. This constitutes a possible trigger for the observed compulsive grooming in SPRED2-/- mice and may, together with hyperplasia of aldosterone-producing cells, contribute to the hyperaldosteronism and homeostatic imbalances.Journal of Biological Chemistry 01/2011; · 4.77 Impact Factor -
Article: Identification of SPRED2 (sprouty-related protein with EVH1 domain 2) as a negative regulator of the hypothalamic-pituitary-adrenal axis.
[show abstract] [hide abstract]
ABSTRACT: Sprouty-related proteins with EVH1 (enabled/vasodilator-stimulated phosphoprotein homology 1) domain (SPREDs) are inhibitors of MAPK signaling. To elucidate SPRED2 in vivo function, we characterized body homeostasis in SPRED2(-/-) mice. They showed a doubled daily water uptake, induced by elevated serum osmolality, originating from increased blood salt load. Accordingly, serum aldosterone was doubled, accompanied by augmented adrenal aldosterone synthase (AS) expression. Surprisingly, serum vasopressin (AVP) was unaltered, and, as evidenced by halved angiotensin II (Ang II) levels, the renin angiotensin system (RAS) was down-regulated. Adrenocorticotropic hormone (ACTH) was significantly elevated in SPRED2(-/-) mice, together with its secretagogue corticotropin-releasing hormone (CRH) and its downstream target corticosterone. ERK phosphorylation in brains was augmented, and hypothalamic CRH mRNA levels were elevated, both contributing to the increased CRH release. Our data were supported by CRH promoter reporter assays in hypothalamic mHypoE-44 cells, revealing a SPRED-dependent inhibition of Ets (ERK/E-twenty-six)-dependent transcription. Furthermore, SPRED suppressed CRH production in these cells. In conclusion, our study suggests that SPRED2 deficiency leads to an increased MAPK signaling, which results in an augmented CRH promoter activity. The subsequent CRH overproduction causes an up-regulation of downstream hypothalamic-pituitary-adrenal (HPA) hormone secretion. This constitutes a possible trigger for the observed compulsive grooming in SPRED2(-/-) mice and may, together with hyperplasia of aldosterone-producing cells, contribute to the hyperaldosteronism and homeostatic imbalances.Journal of Biological Chemistry 01/2011; 286(11):9477-88. · 4.77 Impact Factor -
Article: Spred2 expression during mouse development.
[show abstract] [hide abstract]
ABSTRACT: SPREDs (Sprouty-related proteins with Ena/Vasodilator-stimulated phosphoprotein homology-1 domain) are known membrane-associated modulators of receptor tyrosine kinases by inhibiting the mitogen-activated protein kinase (MAPK) signaling pathway. Although Spred2(-/-) mice exhibit dwarfism and increase of early haematopoiesis, the precise expression and role of SPRED2 in mouse development remains unknown. Here, we demonstrate a detailed Spred2 expression pattern during mouse development using X-Gal stainings from samples of a gene-trapped Spred2 mouse line. In early stages, Spred2 was highly expressed in ectodermal and mesodermal tissues, and later on in developing neural tissue, heart, lung, intestine, urogenital tract, and limbs. Strikingly, we observed that Spred2 was mainly expressed at leading edges of further outgrowing structures and in folds of newly forming grooves. Therefore, SPRED2 is likely involved in the regulation of dynamic developmental processes. These new data provide valuable information for further studies regarding the still enigmatic physiological SPRED functions during mouse development.Developmental Dynamics 09/2010; 239(11):3072-85. · 2.54 Impact Factor -
Article: Reversal of Xenopus Oct25 function by disruption of the POU domain structure.
[show abstract] [hide abstract]
ABSTRACT: Xenopus Oct25 is a POU family subclass V (POU-V) transcription factor with a distinct domain structure. To investigate the contribution of different domains to the function of Oct25, we have performed gain of function analyses. Deletions of the N- or C-terminal regions and of the Hox domain (except its nuclear localization signal) result in mutants being indistinguishable from the wild type protein in the suppression of genes promoting germ layer formation. Deletion of the complete POU domain generates a mutant that has no effect on embryogenesis. However, disruption of the alpha-helical structures in the POU domain, even by a single amino acid mutation, causes reversal of protein function. Overexpression of such mutants leads to dorsalization of embryos and formation of secondary axial structures. The underlying mechanism is an enhanced transcription of genes coding for antagonists of the ligands for ventralizing bone morphogenetic protein and Wnt pathways. Corresponding deletion mutants of Xenopus Oct60, Oct91, or mouse Oct4 also exhibit such a dominant-negative effect. Therefore, our results reveal that the integrity of the POU domain is crucial for the function of POU-V transcription factors in the regulation of genes that promote germ layer formation.Journal of Biological Chemistry 03/2010; 285(11):8408-21. · 4.77 Impact Factor -
Article: Getting a first clue about SPRED functions.
[show abstract] [hide abstract]
ABSTRACT: Spreds form a new protein family with an N-terminal Enabled/VASP homology 1 domain (EVH1), a central c-Kit binding domain (KBD) and a C-terminal Sprouty-related domain (SPR). They are able to inhibit the Ras-ERK signalling pathway after various mitogenic stimulations. In mice, Spred proteins are identified as regulators of bone morphogenesis, hematopoietic processes, allergen-induced airway eosinophilia and hyperresponsiveness. They inhibit cell motility and metastasis and have a high potential as tumor markers and suppressors of carcinogenesis. Moreover, in vertebrates, XtSpreds help together with XtSprouty proteins to coordinate gastrulation and mesoderm specification. Here, we give an overview of this new field and summarize the domain functions, binding partners, expression patterns and the cellular localizations, regulations and functions of Spred proteins and try to give perspectives for future scientific directions.BioEssays 10/2007; 29(9):897-907. · 4.95 Impact Factor -
Article: The VASP-Spred-Sprouty domain puzzle.
[show abstract] [hide abstract]
ABSTRACT: Sprouty-related proteins with an EVH1 domain (Spreds) belong to a new protein family harboring a conserved N-terminal EVH1 domain, which is related to the VASP (vasodilator-stimulated phosphoprotein) EVH1 domain (Enabled/VASP homology 1 domain) and a C-terminal Sprouty-related domain, typical for Sprouty proteins. Spreds were, like Sproutys, initially discovered as inhibitors of the Ras/MAPK pathway, and the SPR (Sprouty-related) domains of both protein families seem to be very important for many protein interactions and cellular processes. VASP was initially characterized as a proline-rich substrate of protein kinases A and G in human platelets and later shown to be a scaffold protein, regulating both signal transduction pathways and the actin filament system. The VASP-EVH1 domain is known to bind specifically to a FP(4) binding motif, which is, for example, present in the focal adhesion proteins vinculin and zyxin. In this review we give a structural and functional overview on these three protein families and ask whether nature plays a modular protein domain puzzle with stable exchangeable elements or if these closely related domains have various functions when pasted in a different protein context.Journal of Biological Chemistry 01/2007; 281(48):36477-81. · 4.77 Impact Factor -
Article: Tissue-specific Spred-2 promoter activity characterized by a gene trap approach.
[show abstract] [hide abstract]
ABSTRACT: Spreds (Sprouty-related proteins with an Ena/Vasodilator-stimulated phosphoprotein homology-1 domain) are a new protein family inhibiting the mitogen-activated protein kinase (MAPK) signaling pathway. Different RNA and protein studies already revealed an almost ubiquitous Spred-2 expression pattern. But until now, only few data were available on the in situ Spred-2 promoter activity. Here, we show a detailed in situ analysis of a mouse strain with a trapped Spred-2 gene, bringing a beta-galactosidase and neomycin fusion gene (beta-geo) under the control of the endogenous Spred-2 promoter. This allowed us to monitor Spred-2 promoter activity in practically every organ and their corresponding sub-compartments. X-Gal staining of newborn and adult mice revealed a nearly congruent Spred-2 promoter activity pattern. Our detailed data provide information for further studies of the still enigmatic physiological functions of Spred-2 in various organs by identifying the tissues with strong Spred-2 promoter activity.Gene Expression Patterns 04/2006; 6(3):247-55. · 2.02 Impact Factor -
Article: Gene disruption of Spred-2 causes dwarfism.
[show abstract] [hide abstract]
ABSTRACT: The impact of the fibroblast growth factor receptor 3 (FGFR3)-mediated signaling pathway on bone growth has been demonstrated by various genetic approaches. Overexpression of fibroblast growth factors (FGFs), several gain-of-function mutations in the FGFR3, and constitutive activation of mitogen-activated protein kinase (MAPK) kinase (MEK1) in chondrocytes have been shown to cause dwarfism in mice by activation of the MAPK signaling pathway. To investigate the previously reported inhibitory role of Spred in the FGFR3/MAPK pathway, we generated mice with a trapped Spred-2 gene. Here we show that lack of functional Spred-2 protein in mice caused a dwarf phenotype, similar to achondroplasia, the most common form of human dwarfism. Spred-2(-/-) mice showed reduced growth and body weight, they had a shorter tibia length, and showed narrower growth plates as compared with wild-type mice. We detected promoter activity and protein expression of Spred-2 in chondrocytes, suggesting an important function of Spred-2 in chondrocytes and bone development. Stimulation of chondrocytes with different FGF concentrations showed earlier and augmented ERK phosphorylation in Spred-2(-/-) chondrocytes in comparison to Spred-2(+/+) chondrocytes. Our observations suggest a model in which loss of Spred-2 inhibits bone growth by inhibiting chondrocyte differentiation through up-regulation of the MAPK signaling pathway.Journal of Biological Chemistry 09/2005; 280(31):28572-80. · 4.77 Impact Factor -
Article: Expression and subcellular localization of Spred proteins in mouse and human tissues.
[show abstract] [hide abstract]
ABSTRACT: Spred-1 and Spred-2 (Sprouty-related protein with an EVH1 domain) are recently described members of the EVH1 (Ena/VASP-homology domain 1) family. Both Spred-1 and Spred-2 are membrane-associated substrates of receptor tyrosine kinases and they act as negative regulators of the Ras pathway upon growth factor stimulation. Since the Spred family members seem to exert overlapping molecular functions, the isotype-specific function of each member remains enigmatic. To date, no comprehensive expression profiling of Spred proteins has been shown. Therefore, we compared mRNA and protein expression patterns of Spred-1 and Spred-2 systematically in mouse organs. Furthermore, we focused on the tissue-specific expression of Spred-2 in adult human tissues, the subcellular localization, and the potential role of Spred-2 in the organism. Our studies show that expression patterns of Spred-1 and Spred-2 differ markedly among various tissues and cell types. In mouse, Spred-1 and Spred-2 were found to be expressed predominantly in brain, whereas Spred-2 was found to be more widely expressed in various adult tissues than Spred-1. In humans, Spred-2 was found to be strongly expressed in glandular epithelia and, at the subcellular level, its immunoreactivity was associated with secretory vesicles. Using confocal microscopy we found Spred-2 to be strongly colocalized with Rab11 and, to a lesser extent, with Rab5a GTPase, an observation that was not made for Spred-1. We conclude that the two members of the recently discovered Spred protein family, Spred-1 and Spred-2, show a highly specific expression pattern in various tissues reflecting a specific physiological role for the individual Spred isoforms in these tissues. Furthermore, it becomes most likely that Spred-2 is involved in the regulation of secretory pathways.Histochemie 01/2005; 122(6):527-38. · 2.59 Impact Factor -
Article: Plasma membrane Ca2+ ATPase 4 is required for sperm motility and male fertility.
[show abstract] [hide abstract]
ABSTRACT: Calcium and Ca(2+)-dependent signals play a crucial role in sperm motility and mammalian fertilization, but the molecules and mechanisms underlying these Ca(2+)-dependent pathways are incompletely understood. Here we show that homozygous male mice with a targeted gene deletion of isoform 4 of the plasma membrane calcium/calmodulin-dependent calcium ATPase (PMCA), which is highly enriched in the sperm tail, are infertile due to severely impaired sperm motility. Furthermore, the PMCA inhibitor 5-(and-6)-carboxyeosin diacetate succinimidyl ester reduced sperm motility in wild-type animals, thus mimicking the effects of PMCA4 deficiency on sperm motility and supporting the hypothesis of a pivotal role of the PMCA4 on the regulation of sperm function and intracellular Ca(2+) levels.Journal of Biological Chemistry 08/2004; 279(27):28220-6. · 4.77 Impact Factor -
Article: Generation and characterization of spred-2 knockout mice
[show abstract] [hide abstract]
ABSTRACT: Spreds are a new Sprouty-related family of membrane-associated proteins inhibiting the MAPK signaling pathway by interacting with Ras and Raf-1. Different studies have already demonstrated the inhibitory function of Spreds in cell culture systems, but the in vivo function of Spreds in the whole organism was still unclear. Therefore, Spred-2 knockout mice were generated using a gene trap approach. The Spred-2 deficiency was verified on RNA and protein levels and the lack of functional Spred-2 protein in mice caused a dwarf phenotype similar to achondroplasia, the most common form of human dwarfism. Spred-2-/- mice showed reduced growth and body weight, they had a shorter tibia length and showed narrower growth plates as compared to wildtype mice. Spred-2 promoter activity and protein expression were detected in chondrocytes, suggesting an important function of Spred-2 in chondrocytes and bone development. Furthermore, stimulation of chondrocytes with different FGF concentrations showed earlier and augmented ERK phosphorylation in Spred-2-/- chondrocytes as compared to Spred-2+/+ chondrocytes. These observations suggest a model, in which loss of Spred-2 inhibits bone growth by inhibiting chondrocyte differentiation through upregulation of the MAPK signaling pathway. An additional observation of Spred-2-/- mice was an increased bleeding phenotype after injuries, whereas the bleeding volume was extremely enlarged and the bleeding time was significantly prolonged. So far, hypertension as cause could be excluded, but to discover the physiological reasons for this phenotype, the different steps of the clotting cascade have to be investigated further. As the Spred-2 promoter activity studies demonstrated a high and specific Spred-2 expression in vascular smooth muscle cells and previous studies showed an interaction of Spreds with RhoA, a key regulator of vascular smooth muscle contraction, the regulation of smooth muscle contractility seems to be a good candidate of this phenomenon. Moreover, Spred-1 and Spred-2 specific antibodies were generated as important tools to study the protein expression patterns in mice. Furthermore, nothing was known about the Spred-2 promoter region and its regulation. Here, a detailed in situ analysis of the physiological promoter activity profile in the gene trapped Spred-2-deficient mouse strain was shown. In these mice, the beta-galactosidase and neomycin fusion gene (β-geo) of the gene trap vector was brought under control of the endogenous Spred-2 promoter, giving the opportunity to monitor Spred-2 promoter activity in practically every organ and their corresponding sub-compartments. X-Gal staining of sections of newborn and adult mice revealed 1) a very high Spred-2 promoter activity in neural tissues and different glands; 2) a high activity in intestinal and uterine smooth muscle cells, and kidney; 3) a low activity in heart, testis, lung, and liver; 4) an almost lacking activity in skeletal muscle and spleen, and 5) very interestingly, a very distinct and strong activity in vascular smooth muscle cells. Moreover, comparison of newborn and adult mouse organs revealed a nearly congruent Spred-2 promoter activity. These detailed data provide valuable information for further studies of the physiological functions of Spred-2 in organs showing strong Spred-2 promoter activity, which are in most of these organs still unclear. Finally, gene targeting vectors for Spred-1 and Spred-2 were cloned, to generate ES cells with a floxed exon 2 of the Spred-1 and Spred-2 gene, respectively. Now, these ES cells are valuable tools to establish conditional knockout mice. This is of major interest to investigate the physiological tissue specific functions of Spred-1 and Spred-2, especially if the double knockout mice are not viable. Spreds gehören zu einer neuen Sprouty-verwandten Familie Membran-assoziierter Proteine, welche den MAPK Signalweg hemmen, indem sie mit Ras und Raf-1 interagieren. In Zellkultur-Systemen haben mehrere Studien bereits die hemmende Funktion von Spred gezeigt, aber die in vivo Funktion im Gesamtorganismus blieb bisher noch ungeklärt. In dieser Arbeit wurden deshalb Spred-2 Knockout Mäuse mithilfe eines Gene-trap Ansatzes generiert. Die Spred-2 Eliminierung konnte auf RNA- und Protein-Ebene bestätigt werden, und der Verlust des funktionsfähigen Spred-2 Proteins führte zu einem Achondroplasie-ähnlichen Zwergenwuchs, der häufigsten Form des menschlichen Zwergenwuchses. Die Spred-2-/- Mäuse waren insgesamt kleiner und hatten ein vermindertes Körpergewicht. Im Vergleich zu Wildtyp Mäusen war die Tibia-Länge verkürzt und die Wachstumsfugen verschmälert. In Knorpelzellen wurde sowohl die Aktivität des Spred-2 Promoters, als auch eine Spred-2 Proteinexpression detektiert, was auf eine wichtige Funktion in Knorpelzellen und bei der Knochenentwicklung schließen lässt. Im Vergleich zu Spred-2+/+ Knorpelzellen zeigte die Stimulierung von Spred-2-/- Knorpelzellen mit verschiedenen FGF-Konzentrationen eine frühere und verstärkte ERK-Phosphorylierung. Diese Beobachtungen deuten auf einen Mechanismus hin, bei dem der Verlust von Spred-2 das Knochenwachstum hemmt, indem die Knorpel-Differenzierung durch eine Hochregulation des MAPK Signalweges gehemmt wird. Spred-2-/- Mäuse zeigten nach Verletzungen eine erhöhte Blutungsneigung, wobei das verlorene Blutvolumen extrem vergrößert und die Blutungszeit signifikant verlängert war. Bislang konnte Bluthochdruck als Ursache ausgeschlossen werden, aber die verschiedenen Stufen der Blutstillung und Gerinnungskaskade müssen noch weiter untersucht werden, um die physiologischen Ursachen dieses Phänotyps ausfindig machen zu können. Untersuchungen der Spred-2 Promotoraktivität zeigten eine starke und spezifische Expression von Spred-2 in glatten Gefäßmuskelzellen. Außerdem zeigten vorhergehende Studien eine Interaktion von Spreds mit RhoA, einem Hauptregulator der Kontraktion glatter Gefäßmuskelzellen. Diesen Beobachtungen zufolge scheint die Regulation der Kontraktilität glatter Gefäßmuskelzellen ein guter Kandidat für dieses Phänomen zu sein. Weiterhin wurden Spred-1 und Spred-2 spezifische Antikörper hergestellt, die als elementares Werkzeug zur Untersuchung der Proteinexpression in der Maus notwendig waren. Bisher gab es noch keine Informationen über die Region und Regulation des Spred-2 Promotors. In dieser Arbeit wurde eine detaillierte in situ Analyse des physiologischen Promotoraktivitätsprofils in der Spred-2 defizienten Mauslinie gezeigt, die mit Hilfe des Gene-trap Vektors generiert wurde. In diesen Mäusen wurde das beta-Galaktosidase/Neomycin-Resistenz Fusionsgen (β-geo) des Gene-trap Vektors unter die Kontrolle des endogenen Spred-2 Promotors gebracht, und lieferte damit die Möglichkeit, die Spred-2 Promotoraktivität in praktisch jedem Organ und den zugehörigen Teilstrukturen beobachten zu können. X-Gal Färbungen von Gewebeschnitten neugeborener und erwachsener Mäuse zeigten 1) eine sehr starke Spred-2 Promotoraktivität in Nervengeweben und verschiedenen Drüsen; 2) eine starke Aktivität in glatten Muskelzellen des Uterus und Verdauungstraktes, sowie der Nieren; 3) eine geringe Aktivität in Herz, Hoden, Lunge und Leber; 4) eine fast fehlende Aktivität in Skelettmuskeln und Milz; und 5) interessanterweise eine starke und eindeutige Aktivität in glatten Gefäßmuskelzellen. Außerdem zeigte der Vergleich zwischen Organen von neugeborenen und erwachsenen Mäusen ein fast identisches Aktivitätsmuster. Diese detaillierten Daten liefern hilfreiche Informationen für weitere Untersuchungen der physiologischen Funktionen von Spred-2 vor allem in Organen mit starker Spred-2 Promotoraktivität, die in den meisten dieser Organe bisher noch immer ungeklärt sind. Zuletzt wurden in dieser Arbeit noch Gene-targeting Vektoren für Spred-1 und Spred-2 kloniert, die zur Generierung von embryonalen Stammzellen mit gefloxtem Exon 2 des Spred-1 bzw. Spred-2 Gens genutzt wurden. Diese embryonalen Stammzellen stehen nun als wertvolle Grundlage zur Etablierung von konditionalen Knockout Mäusen zur Verfügung. Dies ist von großem Interesse, um die physiologischen gewebespezifischen Funktionen von Spred-1 und Spred-2 zu untersuchen, vor allem wenn die Doppel-Knockout Mäuse nicht lebensfähig sein sollten.
Top co-authors
Top Journals
Institutions
-
2005–2011
-
Universität Würzburg
- Institute for Physiology
Würzburg, Bavaria, Germany
-
-
2007
-
Universität Ulm
Ulm, Baden-Wuerttemberg, Germany
-
